Neumora Therapeutics, Inc. (NMRA) income statement
NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.37+0.03 (+9.66%)
Close on Nov 18, 2026Market cap $68.92MP/E –Yield –
Neumora Therapeutics, Inc. financial ratios
See a number that looks wrong?